Rigel Pharmaceuticals Inc
RIGL· Nasdaq
RIGLRigel Pharmaceuticals Inc
Released Mar 5, 2013, during market hours
10-K filed Mar 5, 2013, 64 days after period end · 0001047469-13-002185
No earnings release is on file for this quarter. Its figures came with the 10-K.
| Metric | Q4 2012 | Q4 2011 | Q4 2010dderived from reported figures |
|---|---|---|---|
| EPS Diluted | -$0.30 | -$0.36 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Rigel Pharmaceuticals Inc · CIK 1034842 · Engraved from SEC EDGAR
ended Dec 31, 2012 · filed Mar 5, 2013 · 64 d after period end
+11.0% from the close of Mar 4, 2013 to the close of Mar 6, 2013, the first after the release.
